Clinical Trials Browser

Phase EARLY_PHASE1 × onvansertib × 90 days × Clear all

NCT04005690 2026-02-27

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms